Form 4: Capital Bancorp CIO Reports Equity Transactions

Sentiment:

Insider Transaction Report


Capital Bancorp's EVP and Chief Information Officer, Anguel Lindarev, reported recent acquisitions of common stock, restricted stock units, and stock options, alongside a sale of shares for tax withholding.

Summary

  • Anguel Lindarev, EVP, Chief Information Officer of Capital Bancorp Inc (CBNK), reported transactions on March 2 and March 3, 2026.
  • Acquired 166 shares of common stock on March 3, 2026, at a price of $0, increasing direct beneficial ownership to 577 shares before a subsequent disposal.
  • Disposed of 59 shares of common stock on March 3, 2026, at a price of $29.82, likely for tax withholding purposes, resulting in 518 shares beneficially owned directly.
  • Received a grant of 956 Restricted Stock Units (RSUs) on March 2, 2026, which will vest in four equal annual installments beginning March 2, 2027.
  • Received a grant of 3,694 stock options on March 2, 2026, with an exercise price of $29.41, which will vest in four equal annual installments beginning on the first anniversary of the grant date (March 2, 2027) and expire on March 2, 2031.
  • Exercised/Matured 166 Restricted Stock Units on March 3, 2026, from a previous grant that vests in four equal annual installments beginning March 3, 2026.
  • Following these transactions, Lindarev beneficially owns 518 shares of common stock directly.
  • Derivative securities beneficially owned include 956 RSUs (new grant), 498 RSUs (from a March 3, 2026 vesting grant), and 1,166 RSUs (from a March 18, 2025 vesting grant), totaling 2,620 RSUs.
  • Derivative securities beneficially owned also include 3,694 stock options (new grant), 1,750 stock options (from a March 18, 2025 vesting grant with an exercise price of $20.18), and 2,462 stock options (from a March 3, 2026 vesting grant with an exercise price of $30.51), totaling 7,906 stock options.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive signal, reflecting ongoing executive compensation and alignment of interests through new equity grants, despite a small tax-related sale of shares.

Positives

  • The acquisition of 166 shares of common stock and the grants of 956 Restricted Stock Units and 3,694 stock options align the executive's interests with those of shareholders, indicating continued commitment to the company.
  • The grants of long-term incentive awards (RSUs and stock options) are a standard component of executive compensation, designed to incentivize performance over several years.

Negatives

  • The disposal of 59 shares of common stock, while likely for tax withholding related to RSU vesting, reduces the executive's direct equity ownership.

Future Outlook

The filing indicates future vesting schedules for Restricted Stock Units and Stock Options, with installments beginning on various dates through March 2, 2027, and expiration dates extending to March 2, 2031. These schedules represent future equity compensation realization for the executive.

Industry Context

StockSavvy.ai notes that Form 4 filings detailing executive equity transactions, including grants of restricted stock units and stock options, are a routine aspect of executive compensation across the financial services industry. These grants are designed to align management incentives with long-term shareholder value creation, a common practice among publicly traded banks and financial institutions like Capital Bancorp.

Stakeholder Impact

  • Shareholders: The grants of equity-based compensation to a key executive can be viewed positively as they align the executive's financial interests with the long-term performance of the company, potentially encouraging decisions that enhance shareholder value.

Next Steps

  • Vesting of 956 Restricted Stock Units in four equal annual installments beginning March 2, 2027.
  • Vesting of 3,694 Stock Options in four equal annual installments beginning March 2, 2027.
  • Continued vesting of previously granted Restricted Stock Units and Stock Options according to their respective schedules.

Key Dates

DateDescription
03/18/2025Start of vesting for 1,166 Restricted Stock Units (in three equal annual installments).
03/02/2026Date of earliest transaction; grant date for 956 Restricted Stock Units and 3,694 Stock Options.
03/03/2026Transaction date for common stock acquisition and disposal; exercise/maturity of 166 Restricted Stock Units; start of vesting for 166 Restricted Stock Units (in four equal annual installments).
03/04/2026Signature date of the reporting person.
03/02/2027Start of vesting for 956 Restricted Stock Units (in four equal annual installments) and 3,694 Stock Options (in four equal annual installments).
03/18/2029Expiration date for 1,750 Stock Options.
03/03/2030Expiration date for 2,462 Stock Options.
03/02/2031Expiration date for 3,694 Stock Options.

Keywords

Capital Bancorp, CBNK, Form 4, Insider Transaction, Executive Compensation, Restricted Stock Units, Stock Options, Equity Grant

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.